{"id":"https://openalex.org/W2145763518","doi":"https://doi.org/10.1124/dmd.112.049742","title":"Effect of Ketoconazole on the Pharmacokinetics of the 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 Inhibitor ABT-384 and Its Two Active Metabolites in Healthy Volunteers: Population Analysis of Data from a Drug-Drug Interaction Study","display_name":"Effect of Ketoconazole on the Pharmacokinetics of the 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 Inhibitor ABT-384 and Its Two Active Metabolites in Healthy Volunteers: Population Analysis of Data from a Drug-Drug Interaction Study","publication_year":2013,"publication_date":"2013-02-20","ids":{"openalex":"https://openalex.org/W2145763518","doi":"https://doi.org/10.1124/dmd.112.049742","mag":"2145763518","pmid":"https://pubmed.ncbi.nlm.nih.gov/23431112"},"language":"en","primary_location":{"id":"doi:10.1124/dmd.112.049742","doi":"https://doi.org/10.1124/dmd.112.049742","is_oa":false,"landing_page_url":"https://doi.org/10.1124/dmd.112.049742","pdf_url":null,"source":{"id":"https://openalex.org/S145039780","display_name":"Drug Metabolism and Disposition","issn_l":"0090-9556","issn":["0090-9556","1521-009X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Disposition","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051945295","display_name":"Guohua An","orcid":"https://orcid.org/0000-0002-6498-7663","observed_orcids":["https://orcid.org/0000-0002-6498-7663"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guohua An","raw_affiliation_strings":["Department of Pharmaceutics, University of Florida, 6550 Sanger Road, Orlando, FL 32827, USA. guohuaan@cop.ufl.edu","Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, University of Florida, 6550 Sanger Road, Orlando, FL 32827, USA. guohuaan@cop.ufl.edu","institution_ids":["https://openalex.org/I33213144"]},{"raw_affiliation_string":"Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]},{"raw_affiliation_string":"Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.)","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108899935","display_name":"Wei Liu","orcid":"https://orcid.org/0000-0001-7260-9139","observed_orcids":["https://orcid.org/0000-0001-7260-9139"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Liu","raw_affiliation_strings":["Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.); and Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.); and Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688","https://openalex.org/I33213144"]},{"raw_affiliation_string":"Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]},{"raw_affiliation_string":"Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.)","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087474720","display_name":"David A. Katz","orcid":"https://orcid.org/0000-0002-4400-5669","observed_orcids":["https://orcid.org/0000-0002-4400-5669"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Katz","raw_affiliation_strings":["Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.); and Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.); and Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688","https://openalex.org/I33213144"]},{"raw_affiliation_string":"Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]},{"raw_affiliation_string":"Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.)","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004332028","display_name":"Gerard J. Marek","orcid":"https://orcid.org/0000-0001-8103-4306","observed_orcids":["https://orcid.org/0000-0001-8103-4306"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerard Marek","raw_affiliation_strings":["Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.); and Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.); and Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688","https://openalex.org/I33213144"]},{"raw_affiliation_string":"Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]},{"raw_affiliation_string":"Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.)","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062887347","display_name":"Walid M. Awni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Walid Awni","raw_affiliation_strings":["Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.); and Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.); and Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688","https://openalex.org/I33213144"]},{"raw_affiliation_string":"Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]},{"raw_affiliation_string":"Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.)","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111803176","display_name":"Sandeep Dutta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandeep Dutta","raw_affiliation_strings":["Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.); and Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.); and Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688","https://openalex.org/I33213144"]},{"raw_affiliation_string":"Department of Clinical Pharmacology and Pharmacometrics (W.L., W.A., S.D.) and Neuroscience Clinical Development (D.A.K., G.M.), Global Pharmaceutical R&D, AbbVie, North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]},{"raw_affiliation_string":"Department of Pharmaceutics, University of Florida, Orlando, Florida (G.A.)","institution_ids":["https://openalex.org/I33213144"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":1.0958,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.75002558,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"41","issue":"5","first_page":"1035","last_page":"1045"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8481000065803528,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8481000065803528,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.12300000339746475,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ketoconazole","display_name":"ketoconazole","score":0.9639999866485596},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9599999785423279},{"id":"https://openalex.org/keywords/cyp3a-substrates","display_name":"CYP3A substrates","score":0.7950000166893005},{"id":"https://openalex.org/keywords/bioactive-metabolites","display_name":"bioactive metabolites","score":0.7200000286102295},{"id":"https://openalex.org/keywords/population-pharmacokinetic-model","display_name":"population pharmacokinetic model","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C2781064554","wikidata":"https://www.wikidata.org/wiki/Q407883","display_name":"Ketoconazole","level":3,"score":0.9205865859985352},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7596416473388672},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6149948239326477},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49967193603515625},{"id":"https://openalex.org/C2781067048","wikidata":"https://www.wikidata.org/wiki/Q5955660","display_name":"Hydroxysteroid dehydrogenase","level":4,"score":0.4711548089981079},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.4241408407688141},{"id":"https://openalex.org/C166075782","wikidata":"https://www.wikidata.org/wiki/Q171604","display_name":"11\u03b2-hydroxysteroid dehydrogenase type 1","level":4,"score":0.41762956976890564},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38292062282562256},{"id":"https://openalex.org/C2776317432","wikidata":"https://www.wikidata.org/wiki/Q412547","display_name":"Dehydrogenase","level":3,"score":0.37178993225097656},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3709561228752136},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3419727683067322},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31870460510253906},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.23311984539031982},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14851835370063782},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.07063287496566772},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007654","descriptor_name":"Ketoconazole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008962","descriptor_name":"Models, Theoretical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043205","descriptor_name":"11-beta-Hydroxysteroid Dehydrogenase Type 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1124/dmd.112.049742","doi":"https://doi.org/10.1124/dmd.112.049742","is_oa":false,"landing_page_url":"https://doi.org/10.1124/dmd.112.049742","pdf_url":null,"source":{"id":"https://openalex.org/S145039780","display_name":"Drug Metabolism and Disposition","issn_l":"0090-9556","issn":["0090-9556","1521-009X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Disposition","raw_type":"journal-article"},{"id":"pmid:23431112","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23431112","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism and disposition: the biological fate of chemicals","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W61030567","https://openalex.org/W63938293","https://openalex.org/W165504565","https://openalex.org/W1896956368","https://openalex.org/W1912452802","https://openalex.org/W1965576057","https://openalex.org/W1975785062","https://openalex.org/W1976973182","https://openalex.org/W1984820569","https://openalex.org/W2016125985","https://openalex.org/W2024587809","https://openalex.org/W2031353556","https://openalex.org/W2054886307","https://openalex.org/W2065508314","https://openalex.org/W2073965718","https://openalex.org/W2081213990","https://openalex.org/W2098274706","https://openalex.org/W2117268230","https://openalex.org/W2123002505","https://openalex.org/W2148365177","https://openalex.org/W2150654293","https://openalex.org/W2154740900","https://openalex.org/W2156597872","https://openalex.org/W2162015134","https://openalex.org/W2165065214","https://openalex.org/W2170226754","https://openalex.org/W2403518551","https://openalex.org/W2512454832","https://openalex.org/W6602480327"],"related_works":["https://openalex.org/W2166576133","https://openalex.org/W2334118252","https://openalex.org/W2009050077","https://openalex.org/W1964922902","https://openalex.org/W2089392583","https://openalex.org/W2038418947","https://openalex.org/W2074373747","https://openalex.org/W2563546040","https://openalex.org/W2154256768","https://openalex.org/W1561231235"],"abstract_inverted_index":null,"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}